SlideShare ist ein Scribd-Unternehmen logo

Animal toxicology studies

•Als PPT, PDF herunterladen•
•
S
swati2084
Gesundheit & Medizin
1 von 24
SWATI SARIN
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
PHASES OF DRUG DEVELOPMENT (ANIMAL MAN) PHASE III PHASE IV PHASE I PHASE I PRECLINICAL PHASE II Product Approval (NDA/MAA) Patient studies Entry to man (IND / CTA) None Healthy subjects Safety and tolerability Genetic toxicity (in vivo) Repeat dose toxicity testing + Bioanalysis / Toxicokinetics Drug Metabolism Reproductive Toxicity Testing (teratogenicity) Patients Small scale efficacy studies Patients Large scale multicentre studies Chronic (long term) toxicity testing + Bioanalysis / Toxicokinetics Reproductive Toxicity Testing (fertility and pre/post natal) Carcinogenicity studies Drug Metabolism Patients Large scale post-marketing studies As required Genetic toxicity (in vitro) Single / repeat dose toxicity studies + Bioanalysis / Toxicokinetics Safety Pharmacology Drug Metabolism Lead candidate Identified Clinical Non-clinical MOLECULE
[object Object],[object Object],[object Object],[object Object],[object Object]
TOXICOKINETIC STUDIES ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],b) REPEATED DOSE STUDIES/SUB-ACUTE OR CHRONIC TOXICITY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Fertility and general reproductive performance study Segment II Teratogenicity Segment III Peri and post-natal study Fertility and early embryonic development (rat) Embryo- foetal development (rat & rabbit) Post natal development (rat) (post natal survival of offspring), growth parameters, vital senses, behavioral effects ,[object Object],[object Object],Implantation Embryogenesis
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],CONDUCT OF STUDY
EVALUATION OF RESULT ,[object Object],[object Object],[object Object],[object Object],[object Object]
 

Empfohlen

OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)Naveen K L
 
Oecd guidelines for toxicology studies
Oecd guidelines for toxicology studiesOecd guidelines for toxicology studies
Oecd guidelines for toxicology studiesJasdeep singh brar
 
Acute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animalsAcute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animalsSwaroopaNallabariki
 
Schedule y
Schedule ySchedule y
Schedule yMalla Reddy College of Pharmacy
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesHimikaRathi
 
Acute toxicity studies-425
Acute toxicity studies-425Acute toxicity studies-425
Acute toxicity studies-425jeshicabulsara
 
Oral toxicity
Oral toxicityOral toxicity
Oral toxicityDiana Lou
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugsMy_VivJaan
 

Empfohlen

OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)Naveen K L
 
Oecd guidelines for toxicology studies
Oecd guidelines for toxicology studiesOecd guidelines for toxicology studies
Oecd guidelines for toxicology studiesJasdeep singh brar
 
Acute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animalsAcute and chronic toxicity studies in animals
Acute and chronic toxicity studies in animalsSwaroopaNallabariki
 
Schedule y
Schedule ySchedule y
Schedule yMalla Reddy College of Pharmacy
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesHimikaRathi
 
Acute toxicity studies-425
Acute toxicity studies-425Acute toxicity studies-425
Acute toxicity studies-425jeshicabulsara
 
Oral toxicity
Oral toxicityOral toxicity
Oral toxicityDiana Lou
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugsMy_VivJaan
 
chronic toxicity studies
chronic toxicity studieschronic toxicity studies
chronic toxicity studieskaran chainani
 
Introduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugsIntroduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugsKanthlal SK
 
Subacute toxicity
Subacute toxicitySubacute toxicity
Subacute toxicityvaniarlekar
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Shivam Diwaker
 
Geno toxicity, carcinogenicity and teratogenicity
Geno toxicity, carcinogenicity and teratogenicity Geno toxicity, carcinogenicity and teratogenicity
Geno toxicity, carcinogenicity and teratogenicity Manohar Kuppala
 
OECD Guidelines
OECD GuidelinesOECD Guidelines
OECD GuidelinesUrmila Aswar
 
Preclinical development
Preclinical development Preclinical development
Preclinical development Raghavendra institute of pharmaceutical education and research .
 
Schedule y
Schedule ySchedule y
Schedule ykumargourav40
 
Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Dr Ajay Mandal
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies Santosh Sai
 
Screening methods for Teratogenicity
Screening methods for TeratogenicityScreening methods for Teratogenicity
Screening methods for TeratogenicityHtet Wai Moe
 
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed DoseOECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dosepp_shivgunde
 
Schedule y for toxicity studies
Schedule y for toxicity studiesSchedule y for toxicity studies
Schedule y for toxicity studiesKrushangiShah233
 
Screening of anti ulcer drugs
Screening of anti ulcer drugsScreening of anti ulcer drugs
Screening of anti ulcer drugsDr Roohana Hasan
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discoveryaiswarya thomas
 
Chronopharmacology
ChronopharmacologyChronopharmacology
ChronopharmacologyASHUTOSH MISHRA
 
Chronopharmacology
ChronopharmacologyChronopharmacology
ChronopharmacologyDr. Ashutosh Tiwari
 
Clinical trials its types and designs
Clinical trials its types and designsClinical trials its types and designs
Clinical trials its types and designsDevesh Aggarwal
 
Genotoxicity studies according to oecd guildline.
Genotoxicity studies according to oecd guildline.Genotoxicity studies according to oecd guildline.
Genotoxicity studies according to oecd guildline.Diana Lou
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSRafa Zubair
 
animal toxicity studies
animal toxicity studiesanimal toxicity studies
animal toxicity studiesVishnu Vardhan
 
Principles of toxicology
Principles of toxicologyPrinciples of toxicology
Principles of toxicologyAmna Medani
 

Weitere ähnliche Inhalte

Was ist angesagt?

chronic toxicity studies
chronic toxicity studieschronic toxicity studies
chronic toxicity studieskaran chainani
 
Introduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugsIntroduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugsKanthlal SK
 
Subacute toxicity
Subacute toxicitySubacute toxicity
Subacute toxicityvaniarlekar
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Shivam Diwaker
 
Geno toxicity, carcinogenicity and teratogenicity
Geno toxicity, carcinogenicity and teratogenicity Geno toxicity, carcinogenicity and teratogenicity
Geno toxicity, carcinogenicity and teratogenicity Manohar Kuppala
 
OECD Guidelines
OECD GuidelinesOECD Guidelines
OECD GuidelinesUrmila Aswar
 
Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Dr Ajay Mandal
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies Santosh Sai
 
Screening methods for Teratogenicity
Screening methods for TeratogenicityScreening methods for Teratogenicity
Screening methods for TeratogenicityHtet Wai Moe
 
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed DoseOECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dosepp_shivgunde
 
Schedule y for toxicity studies
Schedule y for toxicity studiesSchedule y for toxicity studies
Schedule y for toxicity studiesKrushangiShah233
 
Screening of anti ulcer drugs
Screening of anti ulcer drugsScreening of anti ulcer drugs
Screening of anti ulcer drugsDr Roohana Hasan
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discoveryaiswarya thomas
 
Chronopharmacology
ChronopharmacologyChronopharmacology
ChronopharmacologyASHUTOSH MISHRA
 
Clinical trials its types and designs
Clinical trials its types and designsClinical trials its types and designs
Clinical trials its types and designsDevesh Aggarwal
 
Genotoxicity studies according to oecd guildline.
Genotoxicity studies according to oecd guildline.Genotoxicity studies according to oecd guildline.
Genotoxicity studies according to oecd guildline.Diana Lou
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSRafa Zubair
 

Was ist angesagt? (20)

chronic toxicity studies
chronic toxicity studieschronic toxicity studies
chronic toxicity studies
 
Introduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugsIntroduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugs
 
Subacute toxicity
Subacute toxicitySubacute toxicity
Subacute toxicity
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
 
Geno toxicity, carcinogenicity and teratogenicity
Geno toxicity, carcinogenicity and teratogenicity Geno toxicity, carcinogenicity and teratogenicity
Geno toxicity, carcinogenicity and teratogenicity
 
OECD Guidelines
OECD GuidelinesOECD Guidelines
OECD Guidelines
 
Preclinical development
Preclinical development Preclinical development
Preclinical development
 
Schedule y
Schedule ySchedule y
Schedule y
 
Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies
 
Screening methods for Teratogenicity
Screening methods for TeratogenicityScreening methods for Teratogenicity
Screening methods for Teratogenicity
 
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed DoseOECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
 
Schedule y for toxicity studies
Schedule y for toxicity studiesSchedule y for toxicity studies
Schedule y for toxicity studies
 
Screening of anti ulcer drugs
Screening of anti ulcer drugsScreening of anti ulcer drugs
Screening of anti ulcer drugs
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discovery
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
 
Clinical trials its types and designs
Clinical trials its types and designsClinical trials its types and designs
Clinical trials its types and designs
 
Genotoxicity studies according to oecd guildline.
Genotoxicity studies according to oecd guildline.Genotoxicity studies according to oecd guildline.
Genotoxicity studies according to oecd guildline.
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGS
 

Andere mochten auch

animal toxicity studies
animal toxicity studiesanimal toxicity studies
animal toxicity studiesVishnu Vardhan
 
Principles of toxicology
Principles of toxicologyPrinciples of toxicology
Principles of toxicologyAmna Medani
 
Safety evaluation of algae...final ppt jun
Safety evaluation of algae...final ppt junSafety evaluation of algae...final ppt jun
Safety evaluation of algae...final ppt junMr. Sharad Khune
 
Overview of OECD Test Guidelines for Thyroid Effects
Overview of OECD Test Guidelines for Thyroid EffectsOverview of OECD Test Guidelines for Thyroid Effects
Overview of OECD Test Guidelines for Thyroid EffectsOECD Environment
 

Andere mochten auch (6)

animal toxicity studies
animal toxicity studiesanimal toxicity studies
animal toxicity studies
 
Principles of toxicology
Principles of toxicologyPrinciples of toxicology
Principles of toxicology
 
Safety evaluation of algae...final ppt jun
Safety evaluation of algae...final ppt junSafety evaluation of algae...final ppt jun
Safety evaluation of algae...final ppt jun
 
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIESACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
 
Overview of OECD Test Guidelines for Thyroid Effects
Overview of OECD Test Guidelines for Thyroid EffectsOverview of OECD Test Guidelines for Thyroid Effects
Overview of OECD Test Guidelines for Thyroid Effects
 
INTRODUCTION TO TOXICOLOGY
INTRODUCTION TO TOXICOLOGYINTRODUCTION TO TOXICOLOGY
INTRODUCTION TO TOXICOLOGY
 

Ă„hnlich wie Animal toxicology studies

GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDYGENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDYRahul Kadam
 
Experimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.pptExperimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.pptKarabiAdak
 
Animal toxicity study requirements for conduct of clinical trial april 13 2019
Animal toxicity study requirements for conduct of clinical trial april 13 2019Animal toxicity study requirements for conduct of clinical trial april 13 2019
Animal toxicity study requirements for conduct of clinical trial april 13 2019Akanksha William
 
Toxicological approach for drug discovery
Toxicological approach for drug discovery Toxicological approach for drug discovery
Toxicological approach for drug discovery Dr Duggirala Mahendra
 
toxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdftoxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdfChijiokeNsofor
 
Toxicity studies
Toxicity studiesToxicity studies
Toxicity studiesAsmaraAslam1
 
Toxicological studies and bioequivalence
Toxicological studies and bioequivalenceToxicological studies and bioequivalence
Toxicological studies and bioequivalencevishnugm
 
SUBHAJIT_OECD422.pptx
SUBHAJIT_OECD422.pptxSUBHAJIT_OECD422.pptx
SUBHAJIT_OECD422.pptxssuser76945d
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studiesAzeemsales
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studiesAzeemsales
 
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdf
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdfgeneral-toxicity-study-designs-jan-willem-van-der-laan_en.pdf
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdfJISUniversity3
 
Introduction to toxicology
Introduction to toxicologyIntroduction to toxicology
Introduction to toxicologyManojKumar109262
 
Drug development process
Drug development processDrug development process
Drug development processnasim arshadi
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoverySuhas Reddy C
 
Introduction to practical pharmacology
Introduction to practical pharmacologyIntroduction to practical pharmacology
Introduction to practical pharmacologyLikith `HV
 
Preclinical & clinical sk
Preclinical & clinical skPreclinical & clinical sk
Preclinical & clinical skSumit Pal
 
Toxi chap 3.ppt
Toxi chap 3.pptToxi chap 3.ppt
Toxi chap 3.pptBarentuShemsu
 

Ă„hnlich wie Animal toxicology studies (20)

GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDYGENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
 
Pravin fianl
Pravin fianlPravin fianl
Pravin fianl
 
Experimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.pptExperimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.ppt
 
Animal toxicity studies
Animal toxicity studiesAnimal toxicity studies
Animal toxicity studies
 
Animal toxicity study requirements for conduct of clinical trial april 13 2019
Animal toxicity study requirements for conduct of clinical trial april 13 2019Animal toxicity study requirements for conduct of clinical trial april 13 2019
Animal toxicity study requirements for conduct of clinical trial april 13 2019
 
Toxicological approach for drug discovery
Toxicological approach for drug discovery Toxicological approach for drug discovery
Toxicological approach for drug discovery
 
toxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdftoxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdf
 
Toxicity studies
Toxicity studiesToxicity studies
Toxicity studies
 
Toxicological studies and bioequivalence
Toxicological studies and bioequivalenceToxicological studies and bioequivalence
Toxicological studies and bioequivalence
 
SUBHAJIT_OECD422.pptx
SUBHAJIT_OECD422.pptxSUBHAJIT_OECD422.pptx
SUBHAJIT_OECD422.pptx
 
Animal toxicity studies
Animal toxicity studiesAnimal toxicity studies
Animal toxicity studies
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studies
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studies
 
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdf
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdfgeneral-toxicity-study-designs-jan-willem-van-der-laan_en.pdf
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdf
 
Introduction to toxicology
Introduction to toxicologyIntroduction to toxicology
Introduction to toxicology
 
Drug development process
Drug development processDrug development process
Drug development process
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug Discovery
 
Introduction to practical pharmacology
Introduction to practical pharmacologyIntroduction to practical pharmacology
Introduction to practical pharmacology
 
Preclinical & clinical sk
Preclinical & clinical skPreclinical & clinical sk
Preclinical & clinical sk
 
Toxi chap 3.ppt
Toxi chap 3.pptToxi chap 3.ppt
Toxi chap 3.ppt
 

Mehr von swati2084

Who expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical productsWho expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical productsswati2084
 
Patient recruitment
Patient recruitmentPatient recruitment
Patient recruitmentswati2084
 
Multicenter trial
Multicenter trialMulticenter trial
Multicenter trialswati2084
 
Methods of patient recruitment
Methods of patient recruitmentMethods of patient recruitment
Methods of patient recruitmentswati2084
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
Food drug and cosmetic act 1938
Food drug and cosmetic act 1938Food drug and cosmetic act 1938
Food drug and cosmetic act 1938swati2084
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drugswati2084
 
HIV and TB coinfection
HIV and TB coinfectionHIV and TB coinfection
HIV and TB coinfectionswati2084
 

Mehr von swati2084 (8)

Who expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical productsWho expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical products
 
Patient recruitment
Patient recruitmentPatient recruitment
Patient recruitment
 
Multicenter trial
Multicenter trialMulticenter trial
Multicenter trial
 
Methods of patient recruitment
Methods of patient recruitmentMethods of patient recruitment
Methods of patient recruitment
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
Food drug and cosmetic act 1938
Food drug and cosmetic act 1938Food drug and cosmetic act 1938
Food drug and cosmetic act 1938
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drug
 
HIV and TB coinfection
HIV and TB coinfectionHIV and TB coinfection
HIV and TB coinfection
 

KĂĽrzlich hochgeladen

PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxCOVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfLUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptxThe next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 

KĂĽrzlich hochgeladen (20)

PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxCOVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
PresentaciĂł "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfLUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptxThe next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 

Animal toxicology studies

  • 2.
  • 3.
  • 4. PHASES OF DRUG DEVELOPMENT (ANIMAL MAN) PHASE III PHASE IV PHASE I PHASE I PRECLINICAL PHASE II Product Approval (NDA/MAA) Patient studies Entry to man (IND / CTA) None Healthy subjects Safety and tolerability Genetic toxicity (in vivo) Repeat dose toxicity testing + Bioanalysis / Toxicokinetics Drug Metabolism Reproductive Toxicity Testing (teratogenicity) Patients Small scale efficacy studies Patients Large scale multicentre studies Chronic (long term) toxicity testing + Bioanalysis / Toxicokinetics Reproductive Toxicity Testing (fertility and pre/post natal) Carcinogenicity studies Drug Metabolism Patients Large scale post-marketing studies As required Genetic toxicity (in vitro) Single / repeat dose toxicity studies + Bioanalysis / Toxicokinetics Safety Pharmacology Drug Metabolism Lead candidate Identified Clinical Non-clinical MOLECULE
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24. Â